Omega Remedies Profile
Key Indicators
- Authorised Capital ₹ 1.20 M
as on 04-01-2025
- Paid Up Capital ₹ 1.10 M
as on 04-01-2025
- Company Age 37 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.65 M
as on 04-01-2025
- Satisfied Charges ₹ 3.60 Cr
as on 04-01-2025
- Revenue 13.24%
(FY 2023)
- Profit 65.76%
(FY 2023)
- Ebitda -3.67%
(FY 2023)
- Net Worth 1.76%
(FY 2023)
- Total Assets -2.95%
(FY 2023)
About Omega Remedies
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.20 M and a paid-up capital of Rs 1.10 M.
The company currently has active open charges totaling ₹0.65 M. The company has closed loans amounting to ₹3.60 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sunil Sahni, Anu Sahni, and Balbhadra Roy serve as directors at the Company.
- CIN/LLPIN
U74899HR1987PTC028241
- Company No.
028241
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Jun 1987
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Karnal, Haryana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Omega Remedies?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sunil Sahni  | Director | 08-Jun-1987 | Current |
| Anu Sahni | Director | 01-Jul-1999 | Current |
| Balbhadra Roy | Director | 17-Nov-2009 | Current |
Financial Performance of Omega Remedies.
Omega Remedies Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 13.24% increase. The company also saw a substantial improvement in profitability, with a 65.76% increase in profit. The company's net worth moved up by a moderate rise of 1.76%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Omega Remedies?
Unlock access to Omega Remedies's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Haryana Financial Corpration Creation Date: 13 Dec 1994 | ₹0.65 M | Open |
State Bank Of India Creation Date: 15 Jul 2019 | ₹2.50 M | Satisfied |
State Bank Of India Creation Date: 20 Oct 2008 | ₹1.50 M | Satisfied |
How Many Employees Work at Omega Remedies?
Omega Remedies has a workforce of 106 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Omega Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Omega Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
